Literature DB >> 16643847

Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells.

Noriko Otsuki1, Yousuke Kamimura, Masaaki Hashiguchi, Miyuki Azuma.   

Abstract

Co-signal receptors provide crucial activating or attenuating signals for T cells. The B and T lymphocyte attenuator (BTLA/CD272) is a third member of co-inhibitory receptors, which belongs to the CD28 immunoglobulin-superfamily. Using monoclonal antibodies (mAbs) against human BTLA, we show that BTLA is constitutively expressed on most CD4+ and CD8+ T cells and its expression progressively decreases upon T cell activation. Polarized Th1 and Th2 cells contained both BTLA-positive and BTLA-negative populations, but the extended culture diminished BTLA expression. Cross-linking BTLA with an agonistic mAb inhibited T cell proliferation and the production of the cytokines IFN-gamma and IL-10 in response to anti-CD3 stimulation. BTLA-mediated inhibition of T cell activation occurred during both primary CD4+ T cell responses and secondary CD4+ and CD8+ T cell responses, suggesting that BTLA ligation sends a constitutive "off" signal to T cells and thus might play an important role in the maintenance of T cell tolerance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16643847     DOI: 10.1016/j.bbrc.2006.03.242

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

1.  BTLA exhibits immune memory for αβ T cells in patients with active pulmonary tuberculosis.

Authors:  Jin-Cheng Zeng; Dong-Zi Lin; Lai-Long Yi; Gan-Bin Liu; Hui Zhang; Wan-Dang Wang; Jun-Ai Zhang; Xian-Jing Wu; Wen-Yu Xiang; Bin Kong; Zheng W Chen; Cong-Yi Wang; Jun-Fa Xu
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

Review 2.  Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications.

Authors:  Lequn Li; Vassiliki A Boussiotis
Journal:  J Mol Med (Berl)       Date:  2006-09-14       Impact factor: 4.599

Review 3.  The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.

Authors:  Marcos W Steinberg; Timothy C Cheung; Carl F Ware
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

4.  Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter.

Authors:  Krit Ritthipichai; Cara L Haymaker; Melisa Martinez; Andrew Aschenbrenner; Xiaohui Yi; Minying Zhang; Charuta Kale; Luis M Vence; Jason Roszik; Yared Hailemichael; Willem W Overwijk; Navin Varadarajan; Roza Nurieva; Laszlo G Radvanyi; Patrick Hwu; Chantale Bernatchez
Journal:  Clin Cancer Res       Date:  2017-07-28       Impact factor: 12.531

5.  Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.

Authors:  Hiroko Kobori; Masaaki Hashiguchi; Jinhua Piao; Moriyuki Kato; Patcharee Ritprajak; Miyuki Azuma
Journal:  Immunology       Date:  2010-02-05       Impact factor: 7.397

6.  The canonical and unconventional ligands of the herpesvirus entry mediator.

Authors:  Timothy C Cheung; Carl F Ware
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

7.  Minority stress and leukocyte gene expression in sexual minority men living with treated HIV infection.

Authors:  Annesa Flentje; Kord M Kober; Adam W Carrico; Torsten B Neilands; Elena Flowers; Nicholas C Heck; Bradley E Aouizerat
Journal:  Brain Behav Immun       Date:  2018-03-13       Impact factor: 7.217

8.  Enhancement of T-cell-mediated anti-tumour immunity via the ectopically expressed glucocorticoid-induced tumour necrosis factor receptor-related receptor ligand (GITRL) on tumours.

Authors:  Jinhua Piao; Yosuke Kamimura; Hideyuki Iwai; Yujia Cao; Keisuke Kikuchi; Masaaki Hashiguchi; Taro Masunaga; Hongsi Jiang; Kouichi Tamura; Shimon Sakaguchi; Miyuki Azuma
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

9.  CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells.

Authors:  Marie-Laure Thibult; Jean-Paul Rivals; Emilie Mamessier; Julie Gertner-Dardenne; Sonia Pastor; Daniel E Speiser; Laurent Derré; Daniel Olive
Journal:  J Mol Med (Berl)       Date:  2012-08-19       Impact factor: 4.599

10.  Aberrant expression of miR-16, B12 and CD272 in peripheral blood mononuclear cells from patients with active tuberculosis.

Authors:  Dongzi Lin; Qiankun Liu; Wei Wang; Yanyun Li; Yumei Li; Bihua Lin; Ziyu Ye; Juan Huang; Xiaolin Yu; Yinwen Chen; Yuezhi Mei; Minyuan Huang; Weiqin Yang; Jie Zhou; Xinguang Liu; Jincheng Zeng
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.